These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8419649)

  • 21. Insertion of the human immunodeficiency virus CD4 receptor into the envelope of vesicular stomatitis virus particles.
    Schubert M; Joshi B; Blondel D; Harmison GG
    J Virol; 1992 Mar; 66(3):1579-89. PubMed ID: 1310767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.
    Moir S; Perreault J; Poulin L
    J Virol; 1996 Nov; 70(11):8019-28. PubMed ID: 8892926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41.
    Chen SS
    J Virol; 1994 Mar; 68(3):2002-10. PubMed ID: 7509005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.
    Nussbaum O; Broder CC; Berger EA
    J Virol; 1994 Sep; 68(9):5411-22. PubMed ID: 8057423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.
    Grimaila RJ; Fuller BA; Rennert PD; Nelson MB; Hammarskjöld ML; Potts B; Murray M; Putney SD; Gray G
    J Virol; 1992 Apr; 66(4):1875-83. PubMed ID: 1548744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein.
    Freed EO; Myers DJ
    J Virol; 1992 Sep; 66(9):5472-8. PubMed ID: 1501283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.
    Sullivan N; Thali M; Furman C; Ho DD; Sodroski J
    J Virol; 1993 Jun; 67(6):3674-9. PubMed ID: 8497077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity.
    Salzwedel K; West JT; Hunter E
    J Virol; 1999 Mar; 73(3):2469-80. PubMed ID: 9971832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
    Elson HF; Dimitrov DS; Blumenthal R
    Mol Membr Biol; 1994; 11(3):165-9. PubMed ID: 7742881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity.
    Thali M; Olshevsky U; Furman C; Gabuzda D; Li J; Sodroski J
    J Virol; 1991 Sep; 65(9):5007-12. PubMed ID: 1870209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The phorbol ester phorbol myristate acetate inhibits human immunodeficiency virus type 1 envelope-mediated fusion by modulating an accessory component(s) in CD4-expressing cells.
    Golding H; Manischewitz J; Vujcic L; Blumenthal R; Dimitrov DS
    J Virol; 1994 Mar; 68(3):1962-9. PubMed ID: 7906314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.
    Mizukami T; Fuerst TR; Berger EA; Moss B
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9273-7. PubMed ID: 2461565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) ectodomain.
    Fenouillet E; Jones I; Powell B; Schmitt D; Kieny MP; Gluckman JC
    J Virol; 1993 Jan; 67(1):150-60. PubMed ID: 8093218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.
    McKeating J; Balfe P; Clapham P; Weiss RA
    J Virol; 1991 Sep; 65(9):4777-85. PubMed ID: 1870202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
    Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
    J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
    Otteken A; Voss G; Hunsmann G
    Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the V1/V2 variable loop structure in the exposure of human immunodeficiency virus type 1 gp120 epitopes induced by receptor binding.
    Wyatt R; Moore J; Accola M; Desjardin E; Robinson J; Sodroski J
    J Virol; 1995 Sep; 69(9):5723-33. PubMed ID: 7543586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.
    Bergeron L; Sullivan N; Sodroski J
    J Virol; 1992 Apr; 66(4):2389-97. PubMed ID: 1548769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.